| Filed | Form | Description | |
|---|---|---|---|
| 9/19/25 | DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | → |
| 9/19/25 | DEF 14A | DEFINITIVE PROXY STATEMENT | → |
| 9/12/24 | DEFA14A | BIO-TECHNE CORP - DEFA14A | → |
| 9/12/24 | DEF 14A | BIO-TECHNE CORP - DEF 14A | → |
| 9/13/23 | DEFA14A | BIO-TECHNE CORP - DEFA14A | → |
| 9/13/23 | DEF 14A | BIO-TECHNE CORP - DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/4/26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| 3/4/26 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | → |
| 2/19/26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| 2/5/26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| 2/3/26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| 11/5/25 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| ↓ | |||
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.